Cargando…
Left DLPFC activity is associated with plasma kynurenine levels and can predict treatment response to escitalopram in major depressive disorder
AIM: To establish treatment response biomarkers that reflect the pathophysiology of depression, it is important to use an integrated set of features. This study aimed to determine the relationship between regional brain activity at rest and blood metabolites related to treatment response to escitalo...
Autores principales: | Kamishikiryo, Toshiharu, Okada, Go, Itai, Eri, Masuda, Yoshikazu, Yokoyama, Satoshi, Takamura, Masahiro, Fuchikami, Manabu, Yoshino, Atsuo, Mawatari, Kazuaki, Numata, Shusuke, Takahashi, Akira, Ohmori, Tetsuro, Okamoto, Yasumasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544423/ https://www.ncbi.nlm.nih.gov/pubmed/35543406 http://dx.doi.org/10.1111/pcn.13373 |
Ejemplares similares
-
Optimized protocol for the extraction of RNA and DNA from frozen whole blood sample stored in a single EDTA tube
por: Yamagata, Hirotaka, et al.
Publicado: (2021) -
Interferon signaling and hypercytokinemia-related gene expression in the blood of antidepressant non-responders
por: Yamagata, Hirotaka, et al.
Publicado: (2023) -
Metabolomic alterations in the blood plasma of older adults with mild cognitive impairment and Alzheimer’s disease (from the Nakayama Study)
por: Ozaki, Tomoki, et al.
Publicado: (2022) -
Kynurenic acid is a potential overlapped biomarker between diagnosis and treatment response for depression from metabolome analysis
por: Erabi, Hisayuki, et al.
Publicado: (2020) -
Age‐related white matter changes revealed by a whole‐brain fiber‐tracking method in bipolar disorder compared to major depressive disorder and healthy controls
por: Masuda, Yoshikazu, et al.
Publicado: (2020)